ALB and Stroke: Second, although fusion of Infestin-4 to human albumin dramatically improved the half-life of this protein in mice, i.e. from 0.3 to 4.6 hours [26], pharmacokinetic characteristics of this molecule may not be optimal for prophylactic regimes in stroke prevention.